[B! SARS-CoV-2] rgfxã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

rgfx id:rgfx

SARS-CoV-2ã«é–¢ã™ã‚‹rgfxã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (56)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

ï½¢æ–°åž‹ã‚³ãƒãƒŠèµ·æºï½£ãƒã‚¤ãƒ‡ãƒ³å ±å‘Šæ›¸ã§åˆ¤æ˜Žã—ãŸã“ã¨
ä¸–ç•Œå…¨ä½“ã§ã™ã§ã«2å„„1700ä¸‡äººãŒæ„ŸæŸ“ã—ã€450ä¸‡äººã‚‚ã®å‘½ã‚’å¥ªã£ã¦ããŸæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã€‚ã€Œ100å¹´ã«1åº¦ã®å±æ©Ÿã€ã¨ã„ã†ãƒ‘ãƒ³ãƒ‡ãƒŸãƒƒã‚¯ãŒäººã€…ã®ç¤¾ä¼šç”Ÿæ´»ã‚’å£Šã—ã€ä¸–ç•ŒçµŒæ¸ˆã‚’æ··ä¹±ã«é™¥ã‚‰ã›ã¦ã„ã‚‹ã€‚ã—ã‹ã—ã€ãã®èµ·æºã¯ä»Šã‚‚ã‚ã‹ã£ã¦ã„ãªã„ã€‚ ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹èµ·æºã«ã¤ã„ã¦ã®3ã¤ã®ãƒã‚¤ãƒ³ãƒˆ ã‚¢ãƒ¡ãƒªã‚«æ”¿åºœã®18ã®æƒ…å ±æ©Ÿé–¢ã‚’çµ±æ‹¬ã™ã‚‹å›½å®¶æƒ…å ±é•·å®˜å®¤ã¯8æœˆ27æ—¥ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹èµ·æºã«ã¤ã„ã¦ã®è©•ä¾¡å ±å‘Šæ›¸ã‚’å…¬è¡¨ã—ãŸã€‚çµæžœã¯ã€ã‚¦ã‚¤ãƒ«ã‚¹ã®èµ·æºã‚’ã‚ãã‚Šã€ååˆ†ãªè¨¼æ‹ ãŒå¾—ã‚‰ã‚Œãšã«æ±ºå®šçš„ãªçµè«–ã‚’å‡ºã›ãªã‹ã£ãŸã€‚ ã¾ãšå ±å‘Šæ›¸ã®ä¸»ãªãƒã‚¤ãƒ³ãƒˆã‚’ã¿ã¦ã¿ãŸã„ã€‚ â‘ ã‚¢ãƒ¡ãƒªã‚«æƒ…å ±ã‚³ãƒŸãƒ¥ãƒ‹ãƒ†ã‚£ãƒ¼ï¼ˆï¼ã‚¢ãƒ¡ãƒªã‚«æƒ…å ±æ©Ÿé–¢ã®ç·ä½“ã‚’æŒ‡ã™ï¼‰ã¯æœ€ã‚‚å¯èƒ½æ€§ã®é«˜ã„ã‚¦ã‚¤ãƒ«ã‚¹ã®èµ·æºèª¬ã¨ã—ã¦ã€æœ€åˆã«å‹•ç‰©ã‹ã‚‰äººã«æ„ŸæŸ“ã—ãŸè‡ªç„¶ç™ºç”Ÿãªã®ã‹ã€ã‚ã‚‹ã„ã¯ä¸å›½ã®æ¦æ¼¢ã‚¦ã‚¤ãƒ«ã‚¹ç ”ç©¶æ‰€ã‹ã‚‰ã®äº‹æ•…ã«ã‚ˆã‚‹æµå‡ºãªã®ã‹ã€è¦‹è§£ãŒ2ã¤ã«åˆ†ã‹ã‚ŒãŸã€‚ å…·ä½“çš„ã«ã¯ã€4ã¤ã®æƒ…å ±æ©Ÿé–¢ã¨å›½å®¶æƒ…å ±ä¼šè°ï¼ˆNICï¼‰ã¯ç¢ºä¿¡
rgfx 2021/09/02
COVID-19

SARS-CoV-2
ãƒªãƒ³ã‚¯
COVID-19ã¯ã‚µã‚¤ãƒˆã‚«ã‚¤ãƒ³ã‚¹ãƒˆãƒ¼ãƒ ç—‡å€™ç¾¤ã§ã‚ã‚‹ | æ—¥æœ¬åŒ»å¸«ä¼š COVID-19æœ‰è˜è€…ä¼šè°
æ³¨ï¼šã“ã®è¨˜äº‹ã¯ã€æœ‰è˜è€…å€‹äººã®æ„è¦‹ã§ã™ã€‚æ—¥æœ¬åŒ»å¸«ä¼šã¾ãŸã¯æ—¥æœ¬åŒ»å¸«ä¼šCOVID-19æœ‰è˜è€…ä¼šè°ã®è¦‹è§£ã§ã¯ãªã„ã“ã¨ã«ç•™æ„ãã ã•ã„ã€‚ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡(COVID-19)ã¯ã€SARS-CoV-2ã‚¦ã‚¤ãƒ«ã‚¹ã«ã‚ˆã‚Šå¼•ãèµ·ã“ã•ã‚Œã‚‹æ„ŸæŸ“ç—‡ã§ã‚ã‚‹ã€‚ ç´„80ï¼…ã®æ„ŸæŸ“è€…ã¯ç„¡ç—‡çŠ¶ã‹è»½ç—‡ã§çµŒéŽã™ã‚‹ãŒã€ç´„20ï¼…ã¯é‡ç—‡è‚ºç‚Žã¨ãªã‚Šã€ãã®ã†ã¡30%ã¯è‡´æ»çš„ãªæ€¥æ€§å‘¼å¸ä¿ƒè¿«ç—‡å€™ç¾¤(ARDS)ã¨ãªã‚‹ã€‚ ç¾æ™‚ç‚¹ã§æœ‰åŠ¹ãªæŠ—ã‚¦ã‚¤ãƒ«ã‚¹è–¬ã‚„ã€ARDSã«å¯¾ã™ã‚‹ç¢ºç«‹ã—ãŸæ²»ç™‚æ–¹æ³•ã¯ãªãã€1æ—¥ã‚‚æ—©ã„æ²»ç™‚è–¬ã®é–‹ç™ºãŒæœ›ã¾ã‚Œã‚‹ã€‚ SARS-CoV-2ã¯ACE2ã‚’å—å®¹ä½“ã¨ã—ã¦æ„ŸæŸ“ã—ã€è‡ªç„¶å…ç–«ç³»ã¨AngII-AT1Rã‚’ä»‹ã—ã¦ã€NF-kBã¨SATA3è»¢å†™å› åã®æ´»æ€§åŒ–ã‚’èª˜å°Žã™ã‚‹ã€‚STAT3ã¯NF-kBã®æ´»æ€§åŒ–ã‚’å¢—å¼·ã™ã‚‹ã“ã¨ã«ã‚ˆã‚Šã€IL-6ãªã©ã®ç‚Žç—‡æ€§ã‚µã‚¤ãƒˆã‚«ã‚¤ãƒ³ç”£ç”Ÿã‚’å¢—å¼·ã™ã‚‹ã€‚ ã“ã®å¢—å¹…å›žè·¯ã¯IL-6ã‚¢ãƒ³ãƒ—ã¨å‘¼ç§°ã•ã‚Œã‚‹ã€‚é–¢ç¯€ãƒªã‚¦ãƒžãƒãªã©ã®æ…¢æ€§ç‚Žç—‡æ€§ç–¾æ‚£ç™º
rgfx 2020/05/30
ã‚µã‚¤ãƒˆã‚«ã‚¤ãƒ³æš´èµ°ã§æ»ã¬ã“ã¨ã«ãªã‚‹ã€ã¨ã„ã†å¥´ã®è©³ç´°

COVID-19

SARS-CoV-2
ãƒªãƒ³ã‚¯
ç±³ãƒ¢ãƒ‡ãƒ«ãƒŠã€ã‚³ãƒãƒŠãƒ¯ã‚¯ãƒãƒ³æŠ—ä½“ç¢ºèªã€€7æœˆã«å¤§è¦æ¨¡æ²»é¨“ - æ—¥æœ¬çµŒæ¸ˆæ–°èž
ã€ãƒ‹ãƒ¥ãƒ¼ãƒ¨ãƒ¼ã‚¯=è¥¿é‚¨ç´˜åã€‘ç±³ãƒã‚¤ã‚ªåŒ»è–¬ãƒ™ãƒ³ãƒãƒ£ãƒ¼ã®ãƒ¢ãƒ‡ãƒ«ãƒŠã¯18æ—¥ã€é–‹ç™ºä¸ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ãƒ¯ã‚¯ãƒãƒ³ã®åˆæœŸã®æ²»é¨“ã®çµæžœãŒæœ‰æœ›ã ã£ãŸã¨ç™ºè¡¨ã—ãŸã€‚ç•°ãªã‚‹é‡ã‚’æŠ•ä¸Žã—ãŸè¤‡æ•°ã®æ²»é¨“å‚åŠ è€…ã‹ã‚‰æŠ—ä½“ã‚’ç¢ºèªã§ããŸã¨ã„ã†ã€‚7æœˆã«ã¯å¤§è¦æ¨¡ãªæ²»é¨“ã«ç§»è¡Œã—ã€æ—©æœŸã®é‡ç”£ã‚’ç›®æŒ‡ã™ã€‚æœ‰åŠ¹ãªãƒ¯ã‚¯ãƒãƒ³ã®ä¾›çµ¦ä½“åˆ¶ãŒæ•´ãˆã°ã€çµŒæ¸ˆã®æœ¬æ ¼çš„ãªå†é–‹ã‚’å¾ŒæŠ¼ã—ã™ã‚‹å¯èƒ½æ€§ãŒã‚ã‚‹ã€‚ãƒ¢ãƒ‡ãƒ«ãƒŠã¯æ–°åž‹ã‚³ãƒãƒŠã®æœ‰åŠ›ãªãƒ¯ã‚¯ãƒãƒ³å€™è£œã€ŒmRNA-1273ã€
rgfx 2020/05/19
COVID-19

SARS-CoV-2
ãƒªãƒ³ã‚¯
ã€å¾Œè—¤å¼˜èŒ‚ã®Weeklyæµ·å¤–ãƒ‹ãƒ¥ãƒ¼ã‚¹ã€‘ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹(SARS-CoV-2)ã¨æˆ¦ã†åŠå°Žä½“æŠ€è¡“(2) ï½žãƒ‡ã‚£ãƒ¼ãƒ—ãƒ©ãƒ¼ãƒ‹ãƒ³ã‚°ã®æœ¬é ˜ãŒç™ºæ®ã•ã‚Œã‚‹å‰µè–¬åˆ†é‡Ž
rgfx 2020/04/24
SARS-CoV-2

folding@home
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã®ã€Œéºä¼æŒ‡ç´‹ã€ã‚’ä½œæˆã—ãŸçµæžœã€æ—¥æœ¬ã«ãƒ¨ãƒ¼ãƒãƒƒãƒ‘åž‹ãŒä¾µå…¥ã—ãŸã“ã¨ãŒåˆ¤æ˜Ž - ãƒŠã‚¾ãƒã‚¸ãƒ¼
æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«å¯¾ã™ã‚‹æœ€æ–°ã®éºä¼åˆ†æžãŒå®Œäº†ã—ã¾ã—ãŸã€‚ 3æœˆåˆæ—¬ã«è¡Œã‚ã‚ŒãŸç ”ç©¶ã§ã¯ã€ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¯æ—¢ã«3ã¤ã®åž‹ã«å¤‰ç•°ã—ã¦ãŠã‚Šã€çˆ†ç™ºçš„ãªæ„ŸæŸ“ãŒèµ·ãã¦ã„ã‚‹ãƒ¨ãƒ¼ãƒãƒƒãƒ‘ã§ã¯ã‚¦ã‚¤ãƒ«ã‚¹ã®æ–°åž‹å¤‰ç•°ä½“ï¼ˆCåž‹ï¼‰ãŒé–¢ä¸Žã—ã¦ã„ã‚‹ã“ã¨ãŒç¤ºå”†ã•ã‚Œã¾ã—ãŸã€‚ ã§ã™ãŒä»Šå›žã€4æœˆã«å…¥ã£ã¦è¡Œã‚ã‚ŒãŸæ–°ã—ã„åˆ†æžã«ã‚ˆã£ã¦ã€ã‚¦ã‚¤ãƒ«ã‚¹ã¯ã‚¢ãƒ¡ãƒªã‚«ä¸Šé™¸å¾Œã‚‚ç‹¬è‡ªã®å¤‰ç•°ã‚’é‚ã’ã¦ã„ã‚‹ã“ã¨ãŒåˆ¤æ˜Žã€‚ã¾ãŸæ—¥æœ¬å›½å†…ã«ãŠã„ã¦ã¯ã€ã“ã‚Œã¾ã§ä¸»æµã ã£ãŸæ±ã‚¢ã‚¸ã‚¢åž‹ä»¥å¤–ã«ã‚‚ã€ã‚¤ã‚¿ãƒªã‚¢ã‚„ã‚¤ã‚®ãƒªã‚¹ã§ã¿ã‚‰ã‚Œã¦ã„ãŸãƒ¨ãƒ¼ãƒãƒƒãƒ‘åž‹ãŒå…¥ã‚Šè¾¼ã¿ã€æ‹¡æ•£ã—ã¯ã˜ã‚ã¦ã„ã‚‹ã“ã¨ãŒæ˜Žã‚‰ã‹ã«ãªã‚Šã¾ã—ãŸã€‚ ã“ã‚Œã¯ã€æ±ã‚¢ã‚¸ã‚¢ã‹ã‚‰ãƒ¨ãƒ¼ãƒãƒƒãƒ‘ã«æ‹¡æ•£ã—ãŸã‚¦ã‚¤ãƒ«ã‚¹ãŒã€ãƒ¨ãƒ¼ãƒãƒƒãƒ‘äººã®è¦³å…‰å®¢ãªã©ã«ç´›ã‚Œã¦ã€æ—¥æœ¬ã«Uã‚¿ãƒ¼ãƒ³ã—ã¦ã„ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚ ä¸€æ–¹ã€ä¸å›½ã‚’ã¯ã˜ã‚ã¨ã—ãŸåˆæœŸã«å¼·ã„å°éŽ–æŽªç½®ãŒã¨ã‚‰ã‚ŒãŸå›½ã§ã¯ã€ãƒ¨ãƒ¼ãƒãƒƒãƒ‘åž‹ã®ã‚¦ã‚¤ãƒ«ã‚¹ã®ã€ŒUã‚¿ãƒ¼ãƒ³ç¾è±¡ã€ã¯ã¾ã æ¤œå‡ºã•ã‚Œã¦ã„ã¾ã›ã‚“ã€‚ æ—¥æœ¬ã«ãŠã‘ã‚‹ãƒ¨ãƒ¼ãƒãƒƒãƒ‘åž‹ã®å¢—åŠ ã¯ã€
rgfx 2020/04/22
SARS-CoV-2
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã€å›žå¾©è€…ã«å…ç–«ã‚ã‚‹ã‹ä¸æ˜Žã€€WHOãŒè¦å‘Š - æ—¥æœ¬çµŒæ¸ˆæ–°èž
ã€ã‚¸ãƒ¥ãƒãƒ¼ãƒ–=ç´°å·å€«å¤ªéƒŽã€‘ä¸–ç•Œä¿å¥æ©Ÿé–¢ï¼ˆWHOï¼‰ã¯13æ—¥ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ„ŸæŸ“è€…ã§å›žå¾©å¾Œã«å†ã³é™½æ€§ã«ãªã‚‹æ‚£è€…ãŒå‡ºã¦ã„ã‚‹ã“ã¨ã«ã¤ã„ã¦ã€å›žå¾©è€…ã«å…ç–«ãŒã¤ã„ã¦ã„ã‚‹ã‹ã¯ä¸æ˜Žã ã¨ã®è¦‹è§£ã‚’ç¤ºã—ãŸã€‚æ¬¡ã«åŒã˜ã‚¦ã‚¤ãƒ«ã‚¹ãŒä¾µå…¥ã—ãŸéš›ã«ã€ç—…åŽŸä½“ã‚’æ”»æ’ƒã™ã‚‹æŠ—ä½“ãŒä½“å†…ã§ååˆ†ã«ä½œã‚‰ã‚Œã¦ã„ãªã„å¯èƒ½æ€§ãŒã‚ã‚‹ãŸã‚ã ã€‚å…ç–«ã‚’æŒã¤äººãŒé™ã‚‰ã‚Œã‚Œã°ã€å¤–å‡ºåˆ¶é™ãªã©ã®è§£é™¤ãŒé…ã‚Œã‚‹å¯èƒ½æ€§ã‚‚ã‚ã‚‹ã€‚WHOã®æ„ŸæŸ“ç—‡å°‚é–€å®¶ã€ãƒžãƒªã‚¢ãƒ»ãƒ•ã‚¡ãƒ³ã‚±ãƒ«ã‚¯
rgfx 2020/04/14
SARS-CoV-2

WHO
ãƒªãƒ³ã‚¯
ã€Œå›žå¾©ã—ãŸäººã®3å‰²ãŒååˆ†ãªæŠ—ä½“ã‚’æŒãŸãšã€ã¨ä¸å›½ã®ç ”ç©¶çµæžœï¼šæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹
ï¼œä¸å›½ã®å¾©æ—¦å¤§å¦ã®ç ”ç©¶ãƒãƒ¼ãƒ ã¯ã€è»½åº¦ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã‹ã‚‰å›žå¾©ã—ãŸ175åã‚’åˆ†æžã—ã€è¢«é¨“è€…ã®ç´„30ï¼…ã¯æŠ—ä½“ãƒ¬ãƒ™ãƒ«ãŒæ¥µã‚ã¦ä½Žã„ã“ã¨ãŒã‚ã‹ã£ãŸ......ï¼ž ç²å¾—å…ç–«ã¨ã¯ã€ç—…åŽŸä½“å›ºæœ‰ã®å…ç–«çš„ãªè¨˜æ†¶ã‚’ç²å¾—ã™ã‚‹ã“ã¨ã§ç”Ÿä½“ã‚’é˜²å¾¡ã™ã‚‹åƒãã§ã‚ã‚Šã€ç—…åŽŸä½“ã«å¯¾æŠ—ã™ã‚‹ãŸã‚ã®ã‚¿ãƒ³ãƒ‘ã‚¯è³ªã€ã™ãªã‚ã¡ã€ŒæŠ—ä½“ã€ãŒé‡è¦ãªå½¹å‰²ã‚’æ‹…ã†ã€‚ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ï¼ˆCOVID-19ï¼‰ã‹ã‚‰å›žå¾©ã—ãŸäººã¯ãã®åŽŸå› ã‚¦ã‚¤ãƒ«ã‚¹ã§ã‚ã‚‹æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹(SARS-CoV-2)ã®å…ç–«ã‚’ç²å¾—ã—ã¦ã„ã‚‹ã¨æŽ¨å®šã•ã‚Œã‚‹ãŒã€æ„ŸæŸ“å¾Œã€ã©ã®ã‚ˆã†ã«å…ç–«ã‚’ç²å¾—ã™ã‚‹ã®ã‹ã€ã©ã‚Œãã‚‰ã„ã®æœŸé–“ã€å…ç–«ãŒæŒç¶šã™ã‚‹ã®ã‹ãªã©ã€è§£æ˜Žã•ã‚Œã¦ã„ãªã„ã“ã¨ã‚‚å¤šã„ã€‚ è¢«é¨“è€…ã®ç´„30ï¼…ã¯æŠ—ä½“ãƒ¬ãƒ™ãƒ«ãŒæ¥µã‚ã¦ä½Žã‹ã£ãŸ ä¸å›½ã®å¾©æ—¦å¤§å¦ã®ç ”ç©¶ãƒãƒ¼ãƒ ã¯ã€2020å¹´2æœˆ26æ™‚ç‚¹ã§è»½åº¦ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã‹ã‚‰å›žå¾©ã—ã€ä¸Šæµ·å…¬è¡†è¡›ç”Ÿè‡¨åºŠã‚»ãƒ³ã‚¿ãƒ¼ã‹ã‚‰é€€é™¢ã—ãŸ175åã®è¡€æ¼¿ã‚’æŽ¡å–ã€‚æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«
rgfx 2020/04/14
COVID-19

SARS-CoV-2
ãƒªãƒ³ã‚¯
ãƒ¯ã‚¯ãƒãƒ³ã¨ã¯
å…ç–«ã¨ã¯ ç§ãŸã¡ãŒç”Ÿãã¦ã„ããŸã‚ã«ã¯ã€å¤–éƒ¨ã‹ã‚‰é…¸ç´ ã‚„æ „é¤Šã‚’å–ã‚Šè¾¼ã‚€å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚ãã®æ™‚ã€æ‹›ã‹ã–ã‚‹å®¢ã§ã‚ã‚‹ã‚¦ã‚¤ãƒ«ã‚¹ã‚„ç´°èŒã‚‚ä½“å†…ã«ä¾µå…¥ã—ã¦ã—ã¾ã„ã¾ã™ã€‚ã‚¦ã‚¤ãƒ«ã‚¹ã‚„ç´°èŒãŒå¢—æ®–ã™ã‚‹ã¨æ„ŸæŸ“ç—‡ãŒç™ºç—‡ã—ã€æœ€æ‚ªã®å ´åˆæ»ã«è‡³ã‚Šã¾ã™ã€‚ã‚¦ã‚¤ãƒ«ã‚¹ã‚„ç´°èŒã¨æˆ¦ã†ã®ãŒå…ç–«ã§ã™ã€‚å…ç–«ã«ã¯è‡ªç„¶å…ç–«ã¨ç²å¾—å…ç–«ãŒã‚ã‚Šã¾ã™ã€‚è‡ªç„¶å…ç–«ã¯ç”Ÿã¾ã‚Œã¤ãå‚™ã‚ã£ã¦ãŠã‚Šã€ã‚¦ã‚¤ãƒ«ã‚¹ã‚„ç´°èŒã«ã¯ã‚ã‚‹ãŒäººé–“ã«ã¯ãªã„æˆåˆ†ã‚’èªè˜ã—ã¦æ”»æ’ƒã—ã¾ã™ã€‚è‡ªç„¶å…ç–«ã®ã¿ã§é€€æ²»ã§ãã‚‹å ´åˆã‚‚ã‚ã‚Šã¾ã™ãŒã€å¤šãã®å ´åˆã¯ä¸ååˆ†ã§ã€ã‚¦ã‚¤ãƒ«ã‚¹ã‚„ç´°èŒã¯å¢—æ®–ã—ã¦ã—ã¾ã„ã¾ã™ã€‚æ¬¡ã«å‡ºå‹•ã™ã‚‹ã®ãŒç²å¾—å…ç–«ã§ã™ã€‚ä¾µå…¥ã—ã¦ããŸã‚¦ã‚¤ãƒ«ã‚¹ã‚„ç´°èŒã ã‘ã‚’èªè˜ã™ã‚‹å…ç–«ç´°èƒžãŒä½œã‚‰ã‚Œã€å¼·åŠ›ã«æ”»æ’ƒã—ã¾ã™ã€‚ã‚¦ã‚¤ãƒ«ã‚¹ã‚„ç´°èŒãŒåˆã‚ã¦ä¾µå…¥ã—ãŸã¨ãã¯ã€ç²å¾—å…ç–«ãŒåƒãã¾ã§1ï¼Œ2é€±é–“ç¨‹åº¦ã‹ã‹ã‚Šã¾ã™ã€‚ã—ã‹ã—ã„ã£ãŸã‚“ç²å¾—å…ç–«ãŒå‡ºæ¥ã‚‹ã¨ã€æ¬¡ã«åŒã˜ã‚¦ã‚¤ãƒ«ã‚¹ã‚„ç´°èŒãŒä¾µå…¥ã—ãŸã¨ãã¯ã€é€Ÿã‚„ã‹ã«æ”»æ’ƒã‚’é–‹å§‹ã—ã¾ã™ã€‚æ˜”ã‹ã‚‰åŒã˜ç—…æ°—ã«2å›žã‹ã‹ã‚‰ãªã„
rgfx 2020/04/09
COVID-19

SARS-CoV-2
ãƒªãƒ³ã‚¯
Folding@homeã‚’Ubuntu 18.10+ã«ã‚¤ãƒ³ã‚¹ãƒˆãƒ¼ãƒ«ã™ã‚‹ã¨ãã«èµ·ãã‚‹åŽ„ä»‹ãªã“ã¨ - Qiita
ã¯ã˜ã‚ã« ã“ã®æ‰‹æ³•ã¯ã‚ãã¾ã§ã‚‚ãƒ¯ãƒ¼ã‚¯ã‚¢ãƒ©ã‚¦ãƒ³ãƒ‰ã§ã™ã€‚ãƒ‘ãƒƒã‚±ãƒ¼ã‚¸ã®ä¾å˜é–¢ä¿‚ã‚’æ„å›³çš„ã«æ±šæŸ“ã—ã¦ã„ã‚‹ç‚¹ã«ã”æ³¨æ„ãã ã•ã„ã€‚ 2000å¹´ã‹ã‚‰ç¨¼åƒã‚’é–‹å§‹ã—ãŸFolding@homeã¨ã„ã†åå‰ã®åˆ†æ•£ã‚³ãƒ³ãƒ”ãƒ¥ãƒ¼ãƒ†ã‚£ãƒ³ã‚°ãƒ—ãƒã‚¸ã‚§ã‚¯ãƒˆãŒã‚ã‚Šã¾ã™ã€‚ ã“ã®ãƒ—ãƒã‚¸ã‚§ã‚¯ãƒˆã¯ã€ã‚ã‚‹ç‰¹å®šã®ã‚¿ãƒ³ãƒ‘ã‚¯è³ªãŒã©ã®ã‚ˆã†ãªç«‹ä½“æ§‹é€ ã«æŠ˜ã‚ŠãŸãŸã¾ã‚Œã‚‹ã‹1ã€ã¨ã„ã†èª²é¡Œã‚’è§£æ±ºã™ã‚‹ãŸã‚ã«å…¨ä¸–ç•Œã®ä½™å‰°è¨ˆç®—è³‡æºã‚’ä½¿ã£ã¦åˆ†åå‹•åŠ›å¦ã‚·ãƒŸãƒ¥ãƒ¬ãƒ¼ã‚·ãƒ§ãƒ³ã‚’èµ°ã‚‰ã›ã‚‹ã‚‚ã®ã§ã™ã€‚ ã“ã®ãƒ—ãƒã‚¸ã‚§ã‚¯ãƒˆã®ä¸€éƒ¨ã«ã¯ã€æ˜¨ä»Šä¸–é–“ã‚’æ‚ªã„æ„å‘³ã§è³‘ã‚ã›ã¦ã„ã‚‹æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚£ãƒ«ã‚¹ï¼ˆSARS-CoV-2ï¼‰ã«å¯¾ã™ã‚‹å–ã‚Šçµ„ã¿ã‚‚å«ã¾ã‚Œã¦ãŠã‚Šã€2020å¹´4æœˆåˆé ã«ãŠã„ã¦ã‚‚æ€¥æ¿€ã«å‚åŠ è€…ãŒå¢—ãˆã¦ã„ã‚‹ç¾çŠ¶ã§ã™2ã€‚ ä¸€æ–¹ã§ã€Linuxç’°å¢ƒç”¨ã®Folding@homeã‚¯ãƒ©ã‚¤ã‚¢ãƒ³ãƒˆã¯ã€ã‚µãƒãƒ¼ãƒˆçµ‚äº†ã—ãŸPython2ç³»ã®ä¾å˜é–¢ä¿‚ã‚’å«ã‚“ã§ãŠã‚Šã€Ubuntu 16.04 LTS/18.04 LTSä»¥å¤–ã®Ubun
rgfx 2020/04/05
folding@home

SARS-CoV-2
ãƒªãƒ³ã‚¯
ãƒšãƒ¼ã‚¸ãŒè¦‹ã¤ã‹ã‚Šã¾ã›ã‚“ã§ã—ãŸ â€“ COVID-19æƒ…å ±å…±æœ‰ â€” COVID19-Information sharing
ãŠæŽ¢ã—ã®ã‚³ãƒ³ãƒ†ãƒ³ãƒ„ã‚’è¦‹ã¤ã‘ã‚‰ã‚Œã¾ã›ã‚“ã§ã—ãŸã€‚æ¤œç´¢ã‚’ãŠè©¦ã—ãã ã•ã„ã€‚ æ¤œç´¢:
rgfx 2020/03/30
COVID-19

SARS-CoV-2
ãƒªãƒ³ã‚¯
LTT Folding Team's Emergency Response to Covid-19
rgfx 2020/03/27
SARS-CoV-2

folding@home
ãƒªãƒ³ã‚¯
ä»Šã‹ã‚‰ã§ã‚‚3åˆ†ã§ã¯ã˜ã‚ã‚‰ã‚Œã‚‹ã‚³ãƒãƒŠè§£æžè²¢çŒ®ã€ŒFolding@homeã€ã®ä½¿ã„æ–¹
rgfx 2020/03/27
ã“ã®ãŸã‚ã«è‡ªå®…ã®Ryzen&Radeonæ©Ÿã‚’ã¤ã‘ã£ã±ã«ã—ã¦ã‚‹ï¼ãªãŠãƒãƒ¼ãƒ ä¸€è¦§ https://folding.extremeoverclocking.com/team_list.php / Summitã®ç†è«–å€¤ã®5å€è¶…ãˆã« https://www.pcgamer.com/folding-home-exascale-supercomputer/

SARS-CoV-2

folding@home
ãƒªãƒ³ã‚¯
ï¼“æœˆï¼’ï¼–æ—¥ BCGã¯ãªãœã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“äºˆé˜²åŠ¹æžœãŒã‚ã‚‹ã®ã‹ï¼ˆï¼’ï¼ï¼‘ï¼˜å¹´ï¼‘æœˆå· Cell Host & Microbe æŽ²è¼‰è«–æ–‡ï¼‰ | AASJãƒ›ãƒ¼ãƒ ãƒšãƒ¼ã‚¸
AASJãƒ›ãƒ¼ãƒ ãƒšãƒ¼ã‚¸ > æ–°ç€æƒ…å ± > è«–æ–‡ã‚¦ã‚©ãƒƒãƒ > ï¼“æœˆï¼’ï¼–æ—¥ã€€BCGã¯ãªãœã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“äºˆé˜²åŠ¹æžœãŒã‚ã‚‹ã®ã‹ï¼ˆï¼’ï¼ï¼‘ï¼˜å¹´ï¼‘æœˆå· Cell Host & Microbe æŽ²è¼‰è«–æ–‡ï¼‰ å‰å›žæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ„ŸæŸ“å‹•æ…‹ã«ã¤ã„ã¦ã®The Lancetè«–æ–‡ã‚’ç´¹ä»‹ã—ãŸæ™‚ï¼ˆhttps://aasj.jp/news/watch/12611ï¼‰èªè€…ã‹ã‚‰BCGãƒ¯ã‚¯ãƒãƒ³ãŒæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“äºˆé˜²ã«åŠ¹æžœãŒãªã„ã‹ç¢ºã‹ã‚ã‚‹æ²»é¨“ãŒé€²ã‚“ã§ã„ã‚‹ã¨ã„ã†æƒ…å ±ãŒé€ã‚‰ã‚Œã¦ããŸã€‚èª¿ã¹ã¦ã¿ã‚‹ã¨ã€ï¼“æœˆï¼’ï¼“æ—¥Scienceã¯ã‚ªãƒ©ãƒ³ãƒ€ãƒŠã‚¤ãƒ¡ãƒ¼ãƒ˜ãƒ³å¤§å¦ã®ã‚°ãƒ«ãƒ¼ãƒ—ãŒä¸å¿ƒã«ãªã£ã¦ã‚ªãƒ©ãƒ³ãƒ€ã§ã¯BCGæŽ¥ç¨®ãŒé€²è¡Œä¸ã§ã‚ã‚‹ã“ã¨ã‚’ãƒ¬ãƒãƒ¼ãƒˆã—ã¦ã„ãŸï¼ˆhttps://www.sciencemag.org/news/2020/03/can-century-old-tb-vaccine-steel-immune-system-against-new-coron
rgfx 2020/03/27
SARS-CoV-2
ãƒªãƒ³ã‚¯
Folding@Home is now equivalent to an exascale supercomputer
rgfx 2020/03/27
"Folding@Homeãƒãƒƒãƒˆãƒ¯ãƒ¼ã‚¯ã¯ã€ç¾åœ¨ã€ExaFLOPã‚’è¶…ãˆã‚‹åˆ†æ•£è¨ˆç®—æ€§èƒ½ã§å®Ÿè¡Œã•ã‚Œã¦ã„ã¾ã™ã€‚ä¸–ç•Œæœ€é€Ÿã®Summitã®ç†è«–å€¤ã®5å€ä»¥ä¸Šã€15ä¸‡å°ä»¥ä¸Šã®RTX 2060ã‚’ã¤ãªãŽåˆã‚ã›ãŸã®ã«ç›¸å½“"

SARS-CoV-2

folding@home
ãƒªãƒ³ã‚¯
Science | AAAS
Cookie Absent This website requires cookies to function properly. Please enable cookies in your browser and try again.
rgfx 2020/03/25
via:ã€Œè‚ºçµæ ¸ã®BCGæŽ¥ç¨®ãŒã€å…ç–«åŠ›ã‚’åºƒç¯„å›²ã«é«˜ã‚ã€ã‚‚ã—ã‹ã—ãŸã‚‰æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚£ãƒ«ã‚¹ã¸ã®æŠµæŠ—åŠ›ã‚‚é«˜ã‚ã‚‹ã‹ã‚‚ã—ã‚Œãªã„ã¨ã„ã†ä»®èª¬ã§ã€è‡¨åºŠè©¦é¨“ãŒå§‹ã¾ã‚‹ã‚‰ã—ã„ã€ https://twitter.com/YukariWatanabe/status/1242579170204540928

SARS-CoV-2
ãƒªãƒ³ã‚¯
COVID-19 Open Research Dataset Challenge (CORD-19)
An AI challenge with AI2, CZI, MSR, Georgetown, NIH & The White House
rgfx 2020/03/25
SARS-CoV-2
ãƒªãƒ³ã‚¯
White House Announces New Partnership to Unleash U.S. Supercomputing Resources to Fight COVID-19 | The White House
rgfx 2020/03/24
SARS-CoV-2
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ²»ç™‚ã®è§£æžãƒœãƒ©ãƒ³ãƒ†ã‚£ã‚¢ã€‚è‡ªå®…ã®ãƒ‘ã‚½ã‚³ãƒ³ã§å¯èƒ½ ã€œåˆ†æ•£ã‚³ãƒ³ãƒ”ãƒ¥ãƒ¼ãƒ†ã‚£ãƒ³ã‚°ã€ŒFolding@homeã€ã«å‚åŠ ã™ã‚‹ã«ã¯
rgfx 2020/03/24
Folding@home

SARS-CoV-2
ãƒªãƒ³ã‚¯
Coronavirus â€“ What weâ€™re doing and how you can help in simple terms â€“ Folding@home
TL;DR: Weâ€™re simulating the dynamics of COVID-19 proteins to hunt for new therapeutic opportunities. Scroll to the bottom of the page to see a list of ways you can help. Proteins are molecular machines that perform many functions we associate with life. They sense the environment (e.g. in taste and smell), perform work (e.g. muscle contraction and breaking down food), and play structural roles (e.
rgfx 2020/03/24
SARS-CoV-2

folding@home
ãƒªãƒ³ã‚¯
Thousands of These Computers Were Mining Cryptocurrency. Now They're Working on Coronavirus Research
rgfx 2020/03/24
SARS-CoV-2

distributed computing

folding@home
ãƒªãƒ³ã‚¯
1 2 3 æ¬¡ã®ãƒšãƒ¼ã‚¸